IEQ Capital
AARD icon

IEQ Capital’s Aardvark Therapeutics AARD Stock Holding History

IEQ Capital’s Portfolio AARD Stock Details AARD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$54.2K Sell
10,294
-28,088
-73% -$171K ﹤0.01% 1906
2026
Q2 		$221K Buy
38,382
+21,897
+133% +$102K ﹤0.01% 1792
2026
Q1 		$62.1K Buy
+16,485
New +$171K ﹤0.01% 1833

Other funds holding AARD

Laurion Capital Management
Laurion Capital Management New York $6.21B AUM 32.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $375B AUM 21.05% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
Jane Street
Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Smith, Moore & Co
Smith, Moore & Co Clayton, Missouri $1.55B AUM 16.43% 1-Year Est. Return

IEQ Capital's AARD Position: Q3 2026 in Review

IEQ Capital reduced its Aardvark Therapeutics (AARD) stake by 73% in Q3 2026, selling an estimated $171K and leaving 10,294 shares worth $54.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1906.

IEQ Capital first reported a position in AARD in Q1 2026 and has held it in 3 quarters since. The position peaked at $221K in Q2 2026. 44 funds tracked by Wall St. Rank hold AARD as of Q3 2026.

  • IEQ Capital held 10,294 shares of Aardvark Therapeutics worth $54.2K as of Q3 2026.
  • IEQ Capital sold 28,088 Aardvark Therapeutics shares in Q3 2026, an estimated $171K.
  • Aardvark Therapeutics made up ﹤0.01% of IEQ Capital's portfolio in Q3 2026, its #1906 holding.
  • IEQ Capital first reported a position in Aardvark Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • IEQ Capital's Aardvark Therapeutics position peaked at $221K in Q2 2026.
  • 44 funds tracked by Wall St. Rank held Aardvark Therapeutics as of Q3 2026.

Based on IEQ Capital's 13F filing for Q3 2026, filed 10 Nov 2026.